Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Bausch Health Companies Inc BHC


Primary Symbol: T.BHC

Bausch Health Companies Inc. is a global diversified pharmaceutical company. The Company develops, manufactures and markets, primarily in the therapeutic areas of gastroenterology (GI), hepatology, neurology and dermatology, and others, through Bausch + Lomb Corporation. Its Salix segment consists of sales in the United States of GI products. Its International segment consists of sales, with... see more

Bullboard (TSX:BHC)

View:
Post by ChartBreaker82on Nov 22, 2024 11:23am

⚠️ CAUTION ⚠️

The BHC stock is consolidating after a decline, having reached a support level. The critical level in the "Strong High" area will be key for a potential reversal or continuation of the ...more  
Post by BearHunter77on Nov 22, 2024 10:20am

Insiders Selling… Should We Be Worried?

Noticed that insiders sold about $83K worth of $BHC stock in the last three months. It's not a massive amount, but it doesn't inspire confidence either. Are they seeing red flags we're ...more  
Post by Duster340on Jul 31, 2024 12:42pm

Earnings Report 📑🧐

 i would not touch this with a 10 foot pole. Bausch Health Companies (NYSE:BHC) is scheduled to announce Q2 earnings results on Thursday, August 1st, before market open. The consensus ...more  
Post by Duster340on Jul 25, 2024 11:53am

Bankruptcy?

Truist Securities analyst Gregory Fraser maintains Bausch Health Companies (NYSE:BHC) with a Hold and lowers the price target from $8 to $7.
Post by whytestockson Jul 10, 2024 7:47pm

How to Take Advantage of moves in (BHC)

Just In: $BHC How to Take Advantage of moves in (BHC)2024-07-10 00:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to ...more  
Post by whytestockson Jun 14, 2024 4:15pm

Bausch Health Reports Promising R&D Trial Updates on Amiseli

NEWS: $BHC Bausch Health Reports Promising R&D Trial Updates on Amiselimod and Scientific Data Presented at International Healthcare ConferencesLAVAL, QC / ACCESSWIRE / June 14, 2024 / Bausch ...more  
Comment by borderguyon Apr 08, 2024 12:59pm

RE:BLCO spinoff

At a ratio of .85 BLCO to BHC shares, a warrant to purchase .85 of a share of BLCO at $4 usd would net BHC over 1.2b usd for debt reduction. Warrants could have an expiry date for early 2025 and would ...more  
Post by borderguyon Apr 08, 2024 12:26pm

BLCO spinoff

Seem like smaller shareholders of the parent company BHC are giving away the gem of the company. During the orginal IPO of BLCO that just over 11% was sold off at fire sell prices with no benifit to ...more  
Post by Betteryear2on Jan 18, 2024 10:31am

Receive Registration Certifications in China T.BHC

Approval Represents an Important Breakthrough in One of the Largest Medical Aesthetics Markets LAVAL, QC / ACCESSWIRE / January 18, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and ...more  
Post by kingscorpionon Nov 08, 2023 10:35pm

Record Q3 revenue for CEMATRIX

Pharmaceutical companies are great investments long term but I bet many of you investors are looking for that 10 bagger. Here it is Cematrix CVX Trading only .195c Just came out with a record breaking ...more  
Post by Betteryear2on Jun 30, 2023 8:51am

Bausch Health’s Bausch + Lomb to Acquire Novartis’ XIIDRA(R)

LAVAL, QC / ACCESSWIRE / June 30, 2023 / Bausch + Lomb Corporation (NYSE/TSX:BLCO), a subsidiary of Bausch Health Companies Inc. (NYSE/TSX:BHC), announced that it has entered into a definitive ...more  
Post by SqueezePlay21on Nov 21, 2022 1:05pm

Massive Short Squeeze Coming on RHT. Don't miss this...

Short interest increased on Reliq Health Technologies right when the company is breaking out. 1st Quarter financial update out in a week. Shorts now over 3.2M and there isn't enough time for them ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities